needle put in their arm and take about the government says they have to take. it is fundamentally against america. harris: congressman mast. how much does it play a role that there is at the judge level a look at this saying no, that mandate cannot stand by the president of the united states? one, that s outstanding that we have judges looking at this and saying yeah, you can t do that to americans. but what we just saw in the press briefing was the court jester for emperor biden saying if you wear masks a little bit longer, if you get more inoculations then maybe we can go back to quote, some version of normal. not normal. let me give her a spoiler alert. florida is back to full normal. second spoiler alert, we re never going back. third spoiler alert, america is never going back either regardless of what the emperor says. harris: one quick follow to this and i ll move to the next
they are expensive relatively speaking to develop, but the federal government is covering the cost and they are delivered free to patients. the other reason there s been less uptake than you might hope is because people who aren t sick enough to be hospitalized, people who are only experiencing mild symptoms or no symptoms with covid don t necessarily want to take a drug, especially a new drug, especially if it s one that you have to go to an infusion center and take a two-hour appointment and have a needle put in your arm and it seems like a scary thing. our experience with these drugs and their use so far, is it clear that they are safe, well tolerated, that they don t have side effects that people should be scared of? you know, i think you hit on a point, rachel, that we ve been trying to socialize broadly, which is there is no harm signal to monoclonal antibodies. these are not harmful therapies. literally there are no serious side effects that accompany these because you potenti
especially a new drug. especially if you have to go to an infusion center and take it to our employment and have a needle put in your arm and it seems like a scary thing. our experience with these drugs and their use so far, is it clear that they are safe, well tolerated, that they don t have side effects of people should be scared of? i think you hit on a point rachel that we have been trying to essentialized broadly which is that there s no harm to the signal to monoclonal antibodies these are not harmful therapies and literally there are no serious side effects that accompany these because you potentially have these soreness and formulations but no major side effects and you also touched on something that i want to emphasize for our viewers. we have moved in the last three months away from getting an iv to get this therapy sent out subpoenas injection it s like insulin those who can jack, into a muscle, every day, now we moved toward subcutaneously formulations of these drugs.
so that s the big change here. the reason why it s important is for the reasons you highlighted. to get fully vaccinated, it s going to take time for that to take effect. so folks that are at risk of dying in realtime, this is a part of the solution. dr. gupta, i feel like part of the reason there hasn t been more uptake for these drugs previously is, number one, because there wasn t a big push to make them available. that seems to be changing. number two, there was a perception they were very expensive. they are expensive relatively speaking to develop, but the federal government is covering the cost and they are delivered free to patients. the other reason there s been less uptake than you might hope is because people who aren t sick enough to be hospitalized, people who are only experiencing mild symptoms or no symptoms with covid don t necessarily want to take a drug, especially a new drug, especially if it s one that you have to go to an infusion center and take a two-hour appoi